-
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
24 Apr 2024 05:00 GMT
… Industry Innovation Award. NORD congratulates Pharming for this achievement.” Stephen … , and life-threatening diseases. Pharming is commercializing and developing an … further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael …
-
Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
19 Apr 2024 17:24 GMT
… debilitating, and life-threatening diseases. Pharming is commercializing and developing an … clinical and commercial prospects, and Pharming's expectations regarding … For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael …
-
‘50 Per Cent More Sodium Than Maggi’: Influencer Revant Himatsingka Aka Food Pharmer Reviews IndiGo's Meals Served on Flight, Airline Responds (Watch Video)
18 Apr 2024 09:35 GMT
… , also referred to as Food Pharmer, recently reviewed the meals offered … Viral, Now-Deleted Post?
Food Pharmer Reviews IndiGo's Meals … /mUyH3VkXnw
— Revant Himatsingka “Food Pharmer” (@foodpharmer2) April 17, 2024
(SocialLY …
-
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
08 Apr 2024 05:00 GMT
… debilitating, and life-threatening diseases. Pharming is commercializing and developing an … early to late-stage development. Pharming is headquartered in Leiden, … For further public information, contact:
Pharming Group, Leiden, The Netherlands
Michael …
-
Pharming Group to participate in April investor conferences
03 Apr 2024 06:00 GMT
… , April 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM … debilitating, and life-threatening diseases. Pharming is commercializing and developing an … For further public information, contact: Pharming Group, Leiden, The Netherlands
Michael …
-
Pharming Group N.V. (PHAR) Q4 2023 Earnings Call Transcript
14 Mar 2024 17:34 GMT
… standing by. Welcome to the Pharming Group N.V. Full Year … Sijmen de Vries, CEO of Pharming Group. Please go ahead sir … launch the team here are Pharming delivered for us. So the … , we continue to invest in Pharming's future growth. I …
-
Pharming Group reports fourth quarter and full year 2023 financial results
14 Mar 2024 06:00 GMT
… including lymphoproliferation and autoimmunity. Pharming is now in the final … increase in payroll expenses. Finally, Pharming incurred additional impairment expenses related … 27
E: pharming@lifespring.nl About Pharming Group N.V. Pharming Group N …
-
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
29 Feb 2024 07:00 GMT
… , February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM … debilitating, and life-threatening diseases. Pharming is commercializing and developing an … further public information, contact: Pharming Group, Leiden, The Netherlands
Michael …
-
Pharming Group to participate in February investor conferences
08 Feb 2024 07:00 GMT
… , February 8, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM … debilitating, and life-threatening diseases. Pharming is commercializing and developing an … further public information, contact: Pharming Group, Leiden, The Netherlands
Michael …
-
Pharming Group (NASDAQ:PHAR) Short Interest Update
26 Jan 2024 18:41 GMT
… million. Analysts anticipate that Pharming Group will post -0. … bought a new stake in Pharming Group stock. Silverberg Bernstein … new position in shares of Pharming Group (NASDAQ:PHAR – Free … analysts' ratings for Pharming Group and related companies with …